EMA Authorised: Pregabalin Sandoz (pregabalin) — Sandoz GmbH

View source ↗

Summary

The EMA authorised the Sandoz generic pregabalin product for anxiety disorders, neuralgia, and epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Epilepsy
• Neuralgia

Drugs mentioned

• Pregabalin Sandoz (pregabalin)

Snippet

Status: Authorised. Therapeutic area: Anxiety Disorders;Neuralgia;Epilepsy. MAH: Sandoz GmbH. Decision date: 02/12/2025